Michael Giannis

648 total citations
6 papers, 430 citations indexed

About

Michael Giannis is a scholar working on Organic Chemistry, Molecular Biology and Polymers and Plastics. According to data from OpenAlex, Michael Giannis has authored 6 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Organic Chemistry, 3 papers in Molecular Biology and 3 papers in Polymers and Plastics. Recurrent topics in Michael Giannis's work include Click Chemistry and Applications (3 papers), Chemical Synthesis and Analysis (3 papers) and Dendrimers and Hyperbranched Polymers (3 papers). Michael Giannis is often cited by papers focused on Click Chemistry and Applications (3 papers), Chemical Synthesis and Analysis (3 papers) and Dendrimers and Hyperbranched Polymers (3 papers). Michael Giannis collaborates with scholars based in Australia and United States. Michael Giannis's co-authors include Scott Henderson, Peter Karellas, Jeremy Ra Paull, Tom D. McCarthy, Graham P. Heery, Barry Matthews, George Holan, Guy Y. Krippner, Secondo Sonza and Mark Zanin and has published in prestigious journals such as PLoS ONE, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Michael Giannis

5 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Giannis Australia	4	233	220	80	74	64	6	430
Graham P. Heery United States	6	163 0.7×	147 0.7×	57 0.7×	34 0.5×	51 0.8×	9	325
Peter Karellas Australia	7	458 2.0×	393 1.8×	128 1.6×	79 1.1×	146 2.3×	7	821
Rafael Ceña‐Diez Spain	11	147 0.6×	103 0.5×	38 0.5×	106 1.4×	19 0.3×	23	318
Maria Jesús Serramía Spain	13	267 1.1×	242 1.1×	73 0.9×	174 2.4×	19 0.3×	23	521
María Isabel Clemente Spain	9	328 1.4×	217 1.0×	44 0.6×	108 1.5×	40 0.6×	11	468
Xiaomeng Wu United States	11	192 0.8×	43 0.2×	81 1.0×	137 1.9×	109 1.7×	14	504
Ernest Moles Spain	11	215 0.9×	46 0.2×	29 0.4×	38 0.5×	95 1.5×	19	439
Ma Jesús Serramía Spain	9	162 0.7×	106 0.5×	27 0.3×	127 1.7×	21 0.3×	10	350
Paolo Di Gianvincenzo Spain	8	110 0.5×	65 0.3×	46 0.6×	42 0.6×	55 0.9×	20	333
Simi Gunaseelan United States	7	287 1.2×	51 0.2×	39 0.5×	61 0.8×	225 3.5×	13	600

Countries citing papers authored by Michael Giannis

Since Specialization

Citations

This map shows the geographic impact of Michael Giannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Giannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Giannis more than expected).

Fields of papers citing papers by Michael Giannis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Giannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Giannis. The network helps show where Michael Giannis may publish in the future.

Co-authorship network of co-authors of Michael Giannis

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Giannis. A scholar is included among the top collaborators of Michael Giannis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Giannis. Michael Giannis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Blyth, Benjamin J., Brian D. Kelly, Michael Giannis, et al.. (2023). Abstract C167: An SN38 dendrimer nanoparticle, DEP irinotecan (SN38-SPL9111), demonstrates efficacy in mouse models of gastrointestinal cancer and augments anti-tumor effects of immune checkpoint blockade and PARP inhibition. Molecular Cancer Therapeutics. 22(12_Supplement). C167–C167.

2.

Kelly, Brian D., Victoria M. McLeod, Susan Jackson, et al.. (2020). Abstract 1716: Anticancer activity of the taxane nanoparticles, DEP® docetaxel and DEP® cabazitaxel. Cancer Research. 80(16_Supplement). 1716–1716. 10 indexed citations

3.

Kelly, Brian D., Victoria M. McLeod, Susan Jackson, et al.. (2020). Abstract 1715: Anti-cancer activity of a SN-38 nanoparticle, DEP® irinotecan, in human colon cancer xenograft models. Cancer Research. 80(16_Supplement). 1715–1715. 2 indexed citations

4.

Tyssen, David, Scott Henderson, Adam Johnson, et al.. (2010). Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity. PLoS ONE. 5(8). e12309–e12309. 132 indexed citations

5.

Kaminskas, Lisa M., Ben J. Boyd, Peter Karellas, et al.. (2007). Impact of Surface Derivatization of Poly-l-lysine Dendrimers with Anionic Arylsulfonate or Succinate Groups on Intravenous Pharmacokinetics and Disposition. Molecular Pharmaceutics. 4(6). 949–961. 40 indexed citations

6.

McCarthy, Tom D., Peter Karellas, Scott Henderson, et al.. (2005). Dendrimers as Drugs: Discovery and Preclinical and Clinical Development of Dendrimer-Based Microbicides for HIV and STI Prevention. Molecular Pharmaceutics. 2(4). 312–318. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact